The company is seeking clearance for Spravato as a monotherapy in adults with treatment-related depression. Currently, it’s used in combination with other drugs.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,